MOAT BIOTECHNOLOGY Corp — Form D/A

MOAT BIOTECHNOLOGY Corp of OKLAHOMA CITY, OK, a company, filed a Form D amendment with the SEC on 2022-10-11. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Todd FoleyDirectorSouth San Francisco, CA
Philip JonesDirectorOklahoma City, OK
Scott RollinsDirectorOklahoma City, OK
Russell RotherDirectorOklahoma City, OK
Richard AlvarezExecutive OfficerPhoenix, AZ
Scott RollinsExecutive OfficerOklahoma City, OK
Russell RotherExecutive OfficerOklahoma City, OK
Tetherex Pharmaceuticals CorporationPromoterOklahoma City, OK
Scott RollinsPromoterOklahoma City, OK
Russell RotherPromoterOklahoma City, OK
Russell P RotherDirectorSteamboat Springs, CO
Russell P RotherExecutive OfficerSteamboat Springs, CO
Russell P RotherPromoterSteamboat Springs, CO
Tetherex Pharmaceuticals P CorporationPromoterOklahoma City, OK
Michael P Moradi-AraghiDirectorOklahoma City, OK
Scott A RollinsDirectorOklahoma City, OK
Scott A RollinsExecutive OfficerOklahoma City, OK
Scott A RollinsPromoterOklahoma City, OK
Todd P FoleyDirectorAlta, WY
Phillip P JonesDirectorNorman, OK
Philip A JonesDirectorOklahoma City, OK
Richard A AlvarezExecutive OfficerOklahoma City, OK
Tetherex Pharmaceuticals A CorporationPromoterOklahoma City, OK
Russell A RotherDirectorOklahoma City, OK
Russell A RotherExecutive OfficerOklahoma City, OK

Other filings by this issuer (3)

FiledFormOfferingSold
2025-10-20D$15.6M$26K
2023-02-09D$20.0M$102K
2022-09-21D$1.0M$1.0M

More